A detailed history of Unionview, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Unionview, LLC holds 2,042 shares of NVO stock, worth $243,140. This represents 0.24% of its overall portfolio holdings.

Number of Shares
2,042
Previous 2,041 0.05%
Holding current value
$243,140
Previous $262,000 11.07%
% of portfolio
0.24%
Previous 0.22%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$122.71 - $146.91 $122 - $146
1 Added 0.05%
2,042 $291,000
Q1 2024

Apr 29, 2024

SELL
$102.11 - $135.92 $23,791 - $31,669
-233 Reduced 10.25%
2,041 $262,000
Q4 2023

Jan 23, 2024

SELL
$87.78 - $105.45 $17,994 - $21,617
-205 Reduced 8.27%
2,274 $235,000
Q3 2023

Oct 30, 2023

BUY
$90.94 - $199.54 $111,219 - $244,037
1,223 Added 97.37%
2,479 $225,000
Q2 2023

Jul 25, 2023

BUY
$155.98 - $172.65 $195,910 - $216,848
1,256 New
1,256 $203,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $269B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Unionview, LLC Portfolio

Follow Unionview, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Unionview, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Unionview, LLC with notifications on news.